The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Arris Intl Inc | SHS | G0551A103 | 249,283 | 9,703,500 | SH | DFND | 1 | 0 | 9,703,500 | 0 | |
| Arsanis Inc | COM | 042873109 | 34,556 | 451,362 | SH | DFND | 0 | 451,362 | 0 | ||
| Cloudera Inc | COM | 18914U100 | 23,380 | 1,415,227 | SH | DFND | 0 | 1,415,227 | 0 | ||
| Denali Therapeutics Inc | COM | 24823R105 | 8,863 | 566,666 | SH | DFND | 0 | 566,666 | 0 | ||
| Snap Inc | CL A | 83304A106 | 38,257 | 2,618,548 | SH | DFND | 0 | 2,618,548 | 0 | ||
| Spero Therapeutics Inc | COM | 84833T103 | 13,072 | 1,112,473 | SH | DFND | 0 | 1,112,473 | 0 | ||
| Square Inc | CL A | 852234103 | 1,019 | 29,400 | SH | DFND | 1 | 0 | 29,400 | 0 | |
| Twitter Inc | COM | 90184L102 | 157 | 6,533 | SH | DFND | 1 | 0 | 6,533 | 0 | |